Hide filtersShow filters × Close Bryan, Garnier & Co advised LIFCO on its acquisition of Physics Forceps dental product assets from GoldenDent Bryan, Garnier & Co makes significant move into the Nordics with the acquisition of Beringer Finance Bryan, Garnier & Co acts as Joint Bookrunner to Genfit on its $155.4 million Nasdaq Initial Public Offering Bryan, Garnier & Co acts as Sole Financial Advisor to Activa Capital and Turenne Capital on the acquisition of Medisys Bryan, Garnier & Co acts as Sole Financial Advisor to HighLife on its €32 million Series B Fundraising Bryan, Garnier & Co acts as Sole Financial Advisor to life insurance platform Quality Insurance Services on its sale to CNP Assurances Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner for MedinCell’s €30 million Euronext Paris IPO Bryan, Garnier & Co acts as Sole Financial Advisor to Montagu Private Equity on the acquisition of Maincare Solutions Bryan, Garnier & Co acts as Financial Advisor to Blueberry Therapeutics on its £10 million Series B Fundraising Bryan, Garnier & Co acts as Joint Bookrunner on Materialise’s USD45 million Follow–On Equity Offering on Nasdaq Bryan, Garnier & Co advises TxCell in its strategic review and subsequent EUR72 million sale to Sangamo Therapeutics to create a CAR-Treg leader Bryan, Garnier & Co acts as Sole Bookrunner on ASIT biotech EUR12 million Convertible Bond Placement
